Market Place
Sourcing Support
CinFina Pharma Presents Positive Phase 1 Results at ObesityWeek®
03 Nov 2024 //
BUSINESSWIRE
CinFina Pharma Presents Posters at ObesityWeek® 2024
23 Oct 2024 //
BUSINESSWIRE
CinRx Pharma Announces Additional $73 Million Financing
30 May 2024 //
BUSINESSWIRE
CinDome Pharma Announces $40 Million Series B Extension
16 May 2024 //
BUSINESSWIRE
CinFina Announces FDA Clearance of NDA Ph 1 Trial for the Treatment of Obesity
26 Mar 2024 //
BUSINESSWIRE
CinRx Pharma Announces First Participant Dosed in CinDome’s Ph2 Deudomperidone
27 Apr 2023 //
BUSINESSWIRE
CinRx Pharma Announces Gavin Samuels, M.D., M.B.A. as Chief Business Officer
18 Oct 2022 //
BUSINESSWIRE
CinRx Announces 1st Study Participant Dosed in CinFina’s PI MAD Study
28 Sep 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.